Preparation and characterization of guluronic acid (cas 15769-56-9) oligosaccharides degraded by a rapid microwave irradiation method
-
Add time:09/26/2019 Source:sciencedirect.com
guluronic acid (cas 15769-56-9) oligosaccharides (GOS) with degree of polymerization (DP) ranging from 1 to 10 were prepared by a rapid microwave degradation method. Polyguluronic acid, fractionated from alginate hydrolysate, was dissolved in dilute ammonia water at a concentration of 20 mg/mL (pH 5) and then hydrolyzed under microwave irradiation (1600 W) at 130 °C for 15 min to produce GOS mixture. The GOS mixture was separated by a Bio-Gel P6 column and ten fractions were obtained. Each GOS fraction was further characterized by electrospray ionization mass spectrometry, 1H NMR, 13C NMR, and 2D NMR spectroscopy techniques. The data showed that the GOS fractions were saturated oligoguluronates with general molecular formula C6nH8n+2O6n+1 (n = 1–10). This microwave degradation method was not only convenient, less time consuming, and environment-friendly, but also produced GOS with high yield (71%) and eliminating a desalting procedure compared to conventional acid hydrolysis method.
We also recommend Trading Suppliers and Manufacturers of guluronic acid (cas 15769-56-9). Pls Click Website Link as below: cas 15769-56-9 suppliers
Prev:An in vitro evaluation of anti-aging effect of guluronic acid (cas 15769-56-9) (G2013) based on enzymatic oxidative stress gene expression using healthy individuals PBMCs
Next:RESEARCH ARTICLE – Pharmaceutics, Drug Delivery and Pharmaceutical TechnologyNanoparticulate Assembly of Mannuronic Acid-and guluronic acid (cas 15769-56-9)-Rich Alginate: Oral Insulin Carrier and Glucose Binder) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- RESEARCH ARTICLE – Pharmaceutics, Drug Delivery and Pharmaceutical TechnologyNanoparticulate Assembly of Mannuronic Acid-and guluronic acid (cas 15769-56-9)-Rich Alginate: Oral Insulin Carrier and Glucose Binder09/27/2019
- An in vitro evaluation of anti-aging effect of guluronic acid (cas 15769-56-9) (G2013) based on enzymatic oxidative stress gene expression using healthy individuals PBMCs09/25/2019
- Anti‐inflammatory and anti‐tumor effects of α-l-guluronic acid (cas 15769-56-9) (G2013) on cancer-related inflammation in a murine breast cancer model09/24/2019
- Effect of alginate size, mannuronic/guluronic acid (cas 15769-56-9) content and pH on particle size, thermodynamics and composition of complexes with β-lactoglobulin09/10/2019
- Physicochemical properties of alginate-based films: Effect of ionic crosslinking and mannuronic and guluronic acid (cas 15769-56-9) ratio09/09/2019
- Impact of hydrolysis conditions on the detection of mannuronic to guluronic acid (cas 15769-56-9) ratio in alginate and its derivatives09/08/2019
- Effects of guluronic acid (cas 15769-56-9) (G2013) on SHIP1, SOCS1 induction and related molecules in TLR4 signaling pathway09/07/2019
- The alginate lyase from Isoptericola halotolerans CGMCC 5336 as a new tool for the production of alginate oligosaccharides with guluronic acid (cas 15769-56-9) as reducing end09/06/2019
- Original articleThe safety and efficacy of guluronic acid (cas 15769-56-9) (G2013) in ankylosing spondylitis: A randomized controlled parallel clinical trial09/05/2019
-
Health and Chemical more >